The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
February 5th 2026
Across 39 patients in 2 cohorts, rapid microbe reduction, high wound closure, restored warmth and sensation, and avoided amputations were observed.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
Report Says US Dietary Panel Poised to Drop Warning on Cholesterol
February 11th 2015If the Dietary Guidelines Advisory Committee drops cholesterol from the list of "nutrients of concern," it will be consistent with a 2013 task force finding as well as the panel's focus on dietary patterns, or the mix of foods that Americans eat and their effect on population health.
Read More
An editorial accompanying the meta-analysis discussed the challenges physicians face when evaluating individual patient needs against guidelines. In the United States, the movement toward reimbursement based on population health measures has raised questions about whether it makes sense for patients to be given multiple medications to achieve small improvements toward targets. Results must be weighed against increased side affects or large out-of-pocket expenditures.
Read More
FDA Announces Measure to Ease Patient Access to Investigational Drugs
February 4th 2015In his blog post on FDAVoice, Peter Lurie MD, MPH, associate FDA commissioner for public health strategy and analysis, announced the introduction of a draft form and a draft guideline that can be used by a physician to request access to an experimental drug or biological product that is still under development.
Read More
Lilly's Glyxambi, First-in-Class Combination Pill, Approved for T2DM
February 2nd 2015The dual inhibitor tablet, a combination of an SGLT-2 inhibitor and a DPP-4 inhibitor, is expected to stimulate the pancreas to produce more insulin and stimulate the liver to produce less glucose, and also prevent glucose reabsorption.
Read More
Meeting enrollment goals for the Affordable Care Act proved the easy part for the HHS in 2015. The hard part will come March 4, 2015, when the US Supreme Court will hear a case that could eliminate financial subsidies for millions who signed up, putting their health coverage at risk.
Read More
A Look at the Unhealthiness of Sitting, and a Call for More Research on Its Effects
January 20th 2015The meta-analysis published today and an accompanying editorial should serve as a wake-up call for healthcare organizations about the costs of caring for aging populations that have spent much of their lives behind desks and watching TV.
Read More
AJMC, Joslin Diabetes Center Join Forces to Host Patient-Centered Diabetes Care in Boston
January 16th 2015The leading peer-reviewed journal in managed care and the world leader in diabetes research and clinical care will present the conference at the Renaissance Boston Waterfront April 16-17, 2015. Faculty presentations and panel discussions will cover clinical, behavioral and technological aspects of care for persons with type 1 and type 2 diabetes mellitus.
Read More
Dr John Santopietro Says People Now See the Connection Between Behavioral, Physical Health
January 9th 2015About 70% of primary care visits actually have a behavioral health component, which has been well known for some time, although people are only now getting serious about investing in mental healthcare, according to John Santopietro, MD, chief clinical officer of behavioral health at Carolinas HealthCare System.
Watch